| Structure |
Chemical Name |
CAS |
MF |
 |
シュードモン酸Dナトリウム |
85178-60-5 |
C26H41NaO9 |
 |
N-DesMethyl SuMatriptan |
88919-51-1 |
C13H19N3O2S |
 |
2,4,6-トリプロピル-1,3,5-トリオキサン |
2396-43-2 |
C12H24O3 |
 |
Bimatoprost Impurity 23 |
|
|
 |
2-epi-(-)-EMtricitabine |
145416-34-8 |
C8H10FN3O3S |
 |
Parent nucleus of cefotiaM hydrochloride |
372092-19-8 |
C13H21N7O3S2 |
![Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)](/CAS/20150408/GIF/111664-35-8.gif) |
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
111664-35-8 |
C22H19NO4 |
 |
6-(2,5-dichlorophenyl)-1,3,5-Triazine-2,4(1H,3H)-dione |
30222-00-5 |
C9H5Cl2N3O2 |
 |
ウリジン, 2'-デオキシ-2'-フルオロ-2'-メチル-, '3',5'-二安息香酸, (2'R)- |
863329-65-1 |
C24H21FN2O7 |
|
|
Celecoxib iMpurity-A |
|
|
|
|
EMtricitabine iMpurity A |
|
|
|
|
RocuroniuMbroMide iMpurity D |
|
|
 |
(3S,4R)-4-(4-Fluorophenyl)piperidine-3-Methanol Hydrochloride |
220548-73-2 |
C12H17ClFNO |
![(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB32735563.gif) |
(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C14H20ClN5O4S |
|
|
Posaconazole iMpurity 5 |
|
|
 |
LaMotrigine IMpurity D |
661463-79-2 |
C9H5Cl2N3O2 |
 |
Topiroxostat Impurity 5 |
1199273-82-9 |
C14H7N7 |
 |
デメチルピペラジニルデスエチルシルデナフィルスルホニルクロリド |
139756-27-7 |
C15H15ClN4O4S |
|
|
Tafluprost Impurity 17 |
|
|
 |
N-Ethoxycarbonyl Ciprofloxacin |
93594-29-7 |
C20H22FN3O5 |
 |
Norepinephrine Tartrate Impurity G |
13062-58-3 |
C22H21NO3 |
 |
Vortioxetine Impurity 1 |
1293489-71-0 |
C17H20N2S |
 |
4-bromo-2-nitropyridine |
909712-10-3 |
C5H3BrN2O2 |
 |
1,3-Bis(1H-1,2,4-triazol-1-yl)-2-propanone |
98414-56-3 |
C7H8N6O |
![2-[[(3aR,4S,6R,6aS)-6-(7-azanyl-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol](/CAS/20180629/GIF/1354945-69-9.gif) |
2-[[(3aR,4S,6R,6aS)-6-(7-azanyl-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol |
1354945-69-9 |
C17H26N6O4S |
|
|
Vonoprazan Impurity E |
|
|
 |
ジサリチルイミド |
1972-71-0 |
C14H11NO4 |
 |
Atomoxetine impurity D |
1643684-02-9 |
C17H21NO |
 |
Diltiazem impurity |
115992-91-1 |
C17H18N2O3S |
 |
Raloxifene EP IMpurity |
1700655-64-6 |
C13H15ClN2O2S |
|
|
Parecoxib Impurity M |
|
|
![Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro-](/CAS/20200119/GIF/1648791-23-4.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro- |
1648791-23-4 |
C29H43N5 |
|
|
Linagliptin Impurity O |
|
|
|
|
Linagliptin Impurity T |
|
|
 |
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzamide |
|
C18H22FN5O3 |
|
|
Etoricoxib Impurity 16 |
|
|
|
|
Ibrutinib Impurity 2 |
2417548-78-6 |
|
|
|
Mirabegron Impurity 14 |
|
|
 |
Vonoprazan Impurity 1 |
881732-90-7 |
C17H17N3O2S |
 |
Atenolol EP Impurity |
|
C14H22N2O3 |
|
|
Cinacalcet Impurity 20 |
|
|
|
|
Dapagliflozin Impurity 11 |
|
|
|
|
Dasatinib Impurity C |
|
|
 |
Etoricoxib impurity Q |
292067-97-1 |
C18H15ClN2S |
|
|
Flucloxacillin Impurity |
|
|
 |
Rizatriptan IMpurity B |
1016900-28-9 |
C13H15ClN5 |
 |
rac Adrenaline IMpurity D |
1095714-91-2 |
C16H19NO3 |
 |
2-イソプロペニル-6-イソプロピルフェノール |
74926-89-9 |
C12H16O |
 |
Irinotecan IMpurity G |
947687-02-7 |
C35H42N4O6 |
 |
ジヒドロキシベンダムスチン |
109882-30-6 |
C16H23N3O4 |
![5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide](/CAS/GIF/325855-74-1.gif) |
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide |
325855-74-1 |
C18H15ClN2O3S |
 |
Lafutidine IMpuritiy B |
174583-84-7 |
C22H29N3O5S |
 |
N,N-ジメシル-2-フェノキシアニリン |
905858-63-1 |
C14H15NO5S2 |
 |
4,5-Dihydro-α,3-diMethyl-5-oxo-1-phenyl-α-sulfo-1H-pyrazole-4-acetic Acid |
1357477-99-6 |
C13H14N2O6S |
|
|
Trelagliptin IMpurity 33 |
|
|
 |
Estradiol Impurity 1 |
57780-81-1 |
C18H24O4 |
 |
Metoprolol IMpurity L |
|
C15H25NO3 |
|
|
Teneligliptin Impurity 14 |
|
|
|
|
Ampicillin EP Impurity P |
|
|
![5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5E)-](/CAS/20200331/GIF/1563176-58-8.gif) |
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5E)- |
1563176-58-8 |
C25H34F2O5 |
![Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R,5S)-tetrahydro-4-hydroxy-5-methyl-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester](/CAS/20200331/GIF/477877-98-8.gif) |
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R,5S)-tetrahydro-4-hydroxy-5-methyl-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester |
477877-98-8 |
C26H40O5 |
 |
1H-1,2,4-Triazole-1-ethanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)-, 4-oxide |
1997296-62-4 |
C13H12F2N6O2 |
 |
para-Hydroxy L-Milnacipran |
688738-11-6 |
C15H22N2O2 |
|
|
Varenicline Impurity 9 |
|
|
|
|
Elagolix Sodium impurity3 |
|
|
 |
Epinephrine Impurity 4 |
94217-53-5 |
C9H13NO3 |
 |
(trans)-4-((2-amino-3,6-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
 |
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)phenol |
|
C21H29NO |
|
|
Dexamethasone EP impurities F |
|
|
![D-Ribofuranose, 1-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,3,5-tris-O-(phenylmethyl)-](/CAS/20200611/GIF/1355049-94-3.gif) |
D-Ribofuranose, 1-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,3,5-tris-O-(phenylmethyl)- |
1355049-94-3 |
C32H32N4O5 |
|
|
Delamanid Impurity 1 |
|
|
![N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide](/CAS/20210111/GIF/1628530-41-5.gif) |
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide |
1628530-41-5 |
C28H24FN3O6 |
 |
Fluorometholone Impurity |
2796-99-8 |
C23H31FO7S |
 |
Verapamil Impurity |
1551304-28-9 |
C12H19NO2 |
 |
Clopidogrel impurity reference substance |
|
C15H14ClNO2S |
|
|
Vildagliptin Impurity |
|
|
|
|
Dihydroxyoxaliplatin(Oxaliplatin Impurity Ⅲ) |
|
|
|
|
cefditoren E-isomer(C=C) |
|
|
|
|
Mixture of Lamivudine Impurity Ⅳ and Impurity Ⅴ |
|
|
 |
2-Ethoxybenzimidohydrazide |
889943-46-8 |
C9H13N3O |
 |
(E)-2-(6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)-2-phenylacetic acid |
|
C18H13NO5 |
 |
8-Epi-cyanocobalamin |
41325-63-7 |
C63H88CoN14O14P |
 |
Lamivudine Impurity 2 |
200396-21-0 |
C18H27N3O4S |
 |
Lamivudine Impurity 1 |
1235712-40-9 |
C8H11N3O4S |
|
|
Moxifloxacin Related Impurity 3 |
|
|
 |
Bisoprolol EP Impurity Q |
1346604-00-9 |
C16H27NO4 |
 |
tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoyl)piperazine-1-carboxylate |
763114-04-1 |
C25H27FN4O4 |
![1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]-](/CAS/GIF/916975-92-3.gif) |
1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]- |
916975-92-3 |
C11H8F3N3O2 |
 |
2-(3-メチル-5-オキソ-1-フェニル-4,5-ジヒドロ-1H-ピラゾール-4-イル)プロパン-2-スルホン酸 |
1323485-71-7 |
C13H16N2O4S |
|
|
Ondansetron Impurity B |
|
|
 |
LeflunoMide EP IMpurity F |
1403564-06-6 |
C12H9F3N2O2 |
|
|
4'-((1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl)biphenyl-2-carboxylic acid |
|
|
|
|
Itraconazole iMpurity D |
|
|
 |
3-amino-2-chloroacrolein |
221615-73-2 |
C3H4ClNO |
 |
3-アミノ-4-ピラゾールカルボニトリル |
16617-46-2 |
C4H4N4 |
 |
BenzaMide, 3,4-bis(cyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)- |
1391052-24-6 |
C20H20Cl2N2O3 |
 |
1-(4-アセチルフェニル)-2-メチル-1-プロパノン |
103931-20-0 |
C12H14O2 |
 |
ButanaMide, 4-hydroxy-N-(1-Methylethyl)- |
42042-66-0 |
C7H15NO2 |
![5H-chroMeno[2,3-b]pyridin-7-ylacetic acid](/CAS/GIF/52549-07-2.gif) |
5H-chroMeno[2,3-b]pyridin-7-ylacetic acid |
52549-07-2 |
C14H11NO3 |
|
|
IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin) |
|
|